In neovascular age-related macular degeneration (AMD), assessing choroidal changes following anti-VEGF therapy through structural optical coherence tomography (OCT) has provided key insights into disease pathophysiology and has helped optimize treatment strategies [17]. This evidence concerns the gene VEGFA and age-related macular degeneration.